Bios Health Group launches innovation circle to advance life sciences
Bios Health Group, a leading strategic and investment partner for life science companies and investors, has officially introduced the Bios Innovation Circle.
Archives for April 16, 2024
Qinecsa Solutions acquires Insife to strengthen pharmacovigilance technology
Qinecsa Solutions (Qinecsa), a lead company in technology-driven end-to-end pharmacovigilance solutions has announced its acquisition of Insife ApS (Insife), a Danish-based firm specializing in innovative pharmacovigilance platforms.
Innovating drug development: Charles River embracing alternatives to animal testing
Charles River Laboratories International, Inc. has unveiled its Alternative Methods Advancement Project (AMAP), a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing.
Nxera Pharma's oral receptor agonist advances in schizophrenia trials with successful preclinical milestone
Nxera Pharma Co., Ltd is celebrating a significant milestone in its collaboration with Neurocrine Biosciences Inc.
Brainbox partners with mBrainTrain to transform neuroimaging through mobile EEG solutions
Brainbox Ltd is thrilled to announce its partnership with mBrainTrain, a collaboration poised to transform the landscape of neuroimaging technology.
DCAT
DCAT Debrief: Lonza's perspective on pharma's path forward with AI and drug development
In a recent discussion with Jan Vertommen, vice president and head of commercial development for the small molecules division at Lonza, key insights were shared regarding the pharmaceutical industry's current landscape and future trajectory.
Remote trials, real challenges: The quest for accurate cough monitoring
Within the rapidly evolving landscape of decentralized clinical trials (DCTs), one critical challenge persists: the accurate monitoring of cough symptoms.